免疫吸附研究在患有后COVID综合征的成年人中Mainz (IAMPOCO) - 一个单盲模拟受控交叉试验,以评估免疫吸附对后COVID综合征的影响
Marco Stortz1, Pascal Klimpke2, Andreas Kommer2
1Department for Nephrology, Rheumatology and Kidney Transplantation, I. Unit for Internal Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstr. 1, Mainz, Germany. marco.stortz@unimedizin-mainz.de.
Trials
|April 2, 2025
概括
这项试验调查了后COVID综合征 (PCS) 的免疫吸附疗法. 它旨在确定是否去除自身抗体可以缓解PCS患者的持续症状.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 临床试验 临床试验
背景情况:
- 后COVID综合征 (PCS) 影响了SARS-CoV-2幸存者的很大一部分,治疗选择有限.
- 新出现的证据表明,自身抗体介导的自身免疫在PCS中可能发挥作用.
- 免疫吸附 (IA) 是一种成熟的体外疗法,用于消除自身免疫性疾病中的循环抗体.
研究的目的:
- 在患有后COVID综合征的患者中评估免疫吸附的治疗疗效.
- 评估IA对PCS症状严重程度和功能结果的影响.
- 研究自身抗体在PCS中的作用以及IA对自身抗体水平的影响.
主要方法:
- 一个单中心,随机化,假控交叉试验 (IAMPOCO) 涉及40名PCS参与者.
- 参与者接受5次IA治疗,然后进行5次假治疗,或者反之亦然,在经过8周的洗期后.
- 主要结局:通过症状得分和手握强度的变化来衡量IA的疗效;次要结局:不良事件和自身抗体的流行/度.
主要成果:
- 由于试验正在进行中,对初级和二级结局的数据正在等待.
- 这项研究旨在提供关于IA在PCS中的有效性的可靠数据.
- 分析将将IA效应与同一患者队列中的假治疗进行比较.
结论:
- IAMPOCO试验解决了对后COVID综合征的基于证据的治疗方法的关键需求.
- 交叉设计和假药控制提高了对IA和假药治疗进行比较的可靠性.
- 结果有可能对PCS治疗策略和临床决策产生重大影响.
相关概念视频
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...